Vimarsana
Biggest News Aggregation in the World

Page 2 - Sunil Singhal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sunil Singhal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sunil Singhal Today - Breaking & Trending Today

FDA approval to targeted imaging agent pafolacianine for use in lung cancer surgery - Vimarsana News

FDA approval to targeted imaging agent pafolacianine for use in lung cancer surgery

More than 130,000 Americans die of lung cancer each year, making lung cancer the leading cause of cancer mortality in the country. Lung cancer mortality is high largely because it tends to be...

FDA approves targeted imaging agent for use in lung cancer surgery - Vimarsana News

FDA approves targeted imaging agent for use in lung cancer surgery

The U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery.

FDA Approves Cancer-Targeting Imaging Agent for Lung Cancer - Vimarsana News

FDA Approves Cancer-Targeting Imaging Agent for Lung Cancer

The FDA approved the imaging agent Cytalux for use in lung cancer cases to help surgeons find and remove previously unidentified tumors.

FDA approves "glowing tumor" imaging agent Cytalux to aid lung cancer surgery - Vimarsana News

FDA approves "glowing tumor" imaging agent Cytalux to aid lung cancer surgery

The U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery. This injectable diagnostic binds to cancerous tissue and...

On Target Laboratories Announces Expanded Indication of CYTALUX® (pafolacianine) injection for Detection of Lung Cancer During Surgery - Vimarsana News

On Target Laboratories Announces Expanded Indication of CYTALUX® (pafolacianine) injection for Detection of Lung Cancer During Surgery

/PRNewswire/ -- On Target Laboratories, Inc., a privately-held biotechnology company developing intraoperative molecular imaging agents to target and...